telpharm limited
telpharm limited Company Information
Company Number
10988023
Next Accounts
Jun 2025
Shareholders
sanjeev suresh samrai
samrai-mahay
View AllGroup Structure
View All
Industry
Dispensing chemist in specialised stores
Registered Address
2 upper russell street, wednesbury, west midlands, WS10 7AR
Website
-telpharm limited Estimated Valuation
Pomanda estimates the enterprise value of TELPHARM LIMITED at £499.9k based on a Turnover of £1.4m and 0.36x industry multiple (adjusted for size and gross margin).
telpharm limited Estimated Valuation
Pomanda estimates the enterprise value of TELPHARM LIMITED at £47.4k based on an EBITDA of £11.1k and a 4.26x industry multiple (adjusted for size and gross margin).
telpharm limited Estimated Valuation
Pomanda estimates the enterprise value of TELPHARM LIMITED at £266.3k based on Net Assets of £127.5k and 2.09x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Telpharm Limited Overview
Telpharm Limited is a live company located in west midlands, WS10 7AR with a Companies House number of 10988023. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in September 2017, it's largest shareholder is sanjeev suresh samrai with a 25% stake. Telpharm Limited is a young, small sized company, Pomanda has estimated its turnover at £1.4m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Telpharm Limited Health Check
Pomanda's financial health check has awarded Telpharm Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
7 Weak
Size
annual sales of £1.4m, make it smaller than the average company (£12.3m)
- Telpharm Limited
£12.3m - Industry AVG
Growth
3 year (CAGR) sales growth of -13%, show it is growing at a slower rate (7.6%)
- Telpharm Limited
7.6% - Industry AVG
Production
with a gross margin of 32.4%, this company has a comparable cost of product (32.4%)
- Telpharm Limited
32.4% - Industry AVG
Profitability
an operating margin of -4.2% make it less profitable than the average company (2.9%)
- Telpharm Limited
2.9% - Industry AVG
Employees
with 18 employees, this is below the industry average (73)
18 - Telpharm Limited
73 - Industry AVG
Pay Structure
on an average salary of £25.8k, the company has an equivalent pay structure (£25.8k)
- Telpharm Limited
£25.8k - Industry AVG
Efficiency
resulting in sales per employee of £77.6k, this is less efficient (£145k)
- Telpharm Limited
£145k - Industry AVG
Debtor Days
it gets paid by customers after 28 days, this is near the average (30 days)
- Telpharm Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 71 days, this is slower than average (64 days)
- Telpharm Limited
64 days - Industry AVG
Stock Days
it holds stock equivalent to 16 days, this is less than average (35 days)
- Telpharm Limited
35 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (14 weeks)
1 weeks - Telpharm Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 90.5%, this is a higher level of debt than the average (59.1%)
90.5% - Telpharm Limited
59.1% - Industry AVG
TELPHARM LIMITED financials
Telpharm Limited's latest turnover from September 2023 is estimated at £1.4 million and the company has net assets of £127.5 thousand. According to their latest financial statements, Telpharm Limited has 18 employees and maintains cash reserves of £32.5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 18 | 19 | 5 | 5 | 5 | 6 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 26,023 | 17,225 | 18,600 | 2,387 | 1,514 | |
| Intangible Assets | 993,750 | 1,060,000 | 1,126,250 | 1,192,500 | 1,258,750 | |
| Investments & Other | ||||||
| Debtors (Due After 1 year) | ||||||
| Total Fixed Assets | 1,019,773 | 1,077,225 | 1,144,850 | 1,194,887 | 1,260,264 | |
| Stock & work in progress | 41,676 | 45,443 | 40,785 | 41,357 | 48,298 | |
| Trade Debtors | 107,673 | 157,277 | 406,153 | 216,835 | 185,552 | |
| Group Debtors | ||||||
| Misc Debtors | 137,192 | 152,023 | 32,480 | |||
| Cash | 32,528 | 99,580 | 322,986 | 114,198 | 33,396 | 300 |
| misc current assets | ||||||
| total current assets | 319,069 | 454,323 | 802,404 | 372,390 | 267,246 | 300 |
| total assets | 1,338,842 | 1,531,548 | 1,947,254 | 1,567,277 | 1,527,510 | 300 |
| Bank overdraft | 33,600 | 23,776 | 21,494 | |||
| Bank loan | ||||||
| Trade Creditors | 183,997 | 139,527 | 190,184 | 1,533,740 | 1,508,276 | |
| Group/Directors Accounts | ||||||
| other short term finances | ||||||
| hp & lease commitments | ||||||
| other current liabilities | 889,236 | 1,033,329 | 1,506,818 | |||
| total current liabilities | 1,106,833 | 1,196,632 | 1,718,496 | 1,533,740 | 1,508,276 | |
| loans | 104,480 | 135,943 | 161,511 | 234,571 | 206,563 | |
| hp & lease commitments | ||||||
| Accruals and Deferred Income | ||||||
| other liabilities | ||||||
| provisions | ||||||
| total long term liabilities | 104,480 | 135,943 | 161,511 | 234,571 | 206,563 | |
| total liabilities | 1,211,313 | 1,332,575 | 1,880,007 | 1,768,311 | 1,714,839 | |
| net assets | 127,529 | 198,973 | 67,247 | -201,034 | -187,329 | 300 |
| total shareholders funds | 127,529 | 198,973 | 67,247 | -201,034 | -187,329 | 300 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | 3,021 | 2,970 | 2,277 | 277 | 267 | |
| Amortisation | 66,250 | 66,250 | 66,250 | 66,250 | 66,250 | |
| Tax | ||||||
| Stock | -3,767 | 4,658 | -572 | -6,941 | 48,298 | |
| Debtors | -64,435 | -129,333 | 221,798 | 31,283 | 185,552 | |
| Creditors | 44,470 | -50,657 | -1,343,556 | 25,464 | 1,508,276 | |
| Accruals and Deferred Income | -144,093 | -473,489 | 1,506,818 | |||
| Deferred Taxes & Provisions | ||||||
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | ||||||
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | ||||||
| Group/Directors Accounts | ||||||
| Other Short Term Loans | ||||||
| Long term loans | -31,463 | -25,568 | -73,060 | 28,008 | 206,563 | |
| Hire Purchase and Lease Commitments | ||||||
| other long term liabilities | ||||||
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | -67,052 | -223,406 | 208,788 | 80,802 | 33,096 | 300 |
| overdraft | 9,824 | 2,282 | 21,494 | |||
| change in cash | -76,876 | -225,688 | 187,294 | 80,802 | 33,096 | 300 |
telpharm limited Credit Report and Business Information
Telpharm Limited Competitor Analysis
Perform a competitor analysis for telpharm limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in WS10 area or any other competitors across 12 key performance metrics.
telpharm limited Ownership
TELPHARM LIMITED group structure
Telpharm Limited has no subsidiary companies.
Ultimate parent company
TELPHARM LIMITED
10988023
telpharm limited directors
Telpharm Limited currently has 4 directors. The longest serving directors include Mr Sanjeev Samrai (Sep 2017) and Mrs Shindo Samrai (Jan 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Sanjeev Samrai | United Kingdom | 42 years | Sep 2017 | - | Director |
| Mrs Shindo Samrai | England | 71 years | Jan 2018 | - | Director |
| Mr Sarwan Samrai | England | 70 years | Jan 2018 | - | Director |
| Mrs Sharmila Samrai Mahay | England | 45 years | Mar 2021 | - | Director |
P&L
September 2023turnover
1.4m
-13%
operating profit
-58.2k
0%
gross margin
32.4%
-3.37%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
127.5k
-0.36%
total assets
1.3m
-0.13%
cash
32.5k
-0.67%
net assets
Total assets minus all liabilities
Similar Companies
telpharm limited company details
company number
10988023
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
September 2017
age
8
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
September 2023
previous names
N/A
accountant
DHILLON ACCOUNTANTS LIMITED
auditor
-
address
2 upper russell street, wednesbury, west midlands, WS10 7AR
Bank
-
Legal Advisor
-
telpharm limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to telpharm limited.
telpharm limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for TELPHARM LIMITED. This can take several minutes, an email will notify you when this has completed.
telpharm limited Companies House Filings - See Documents
| date | description | view/download |
|---|
